- Home
- ARAY vs CATX Comparison
ARAY vs CATX Comparison
Compare ARAY & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARAY
- CATX
- Stock Information
- Founded
- ARAY 1990
- CATX 1983
- Country
- ARAY United States
- CATX United States
- Employees
- ARAY N/A
- CATX N/A
- Industry
- ARAY Medical/Dental Instruments
- CATX Medical/Dental Instruments
- Sector
- ARAY Health Care
- CATX Health Care
- Exchange
- ARAY Nasdaq
- CATX Nasdaq
- Market Cap
- ARAY 229.3M
- CATX 239.0M
- IPO Year
- ARAY 2007
- CATX N/A
- Fundamental
- Price
- ARAY $1.37
- CATX $3.93
- Analyst Decision
- ARAY
- CATX Strong Buy
- Analyst Count
- ARAY 0
- CATX 11
- Target Price
- ARAY N/A
- CATX $12.90
- AVG Volume (30 Days)
- ARAY 653.3K
- CATX 977.5K
- Earning Date
- ARAY 08-13-2025
- CATX 08-13-2025
- Dividend Yield
- ARAY N/A
- CATX N/A
- EPS Growth
- ARAY N/A
- CATX N/A
- EPS
- ARAY 0.01
- CATX N/A
- Revenue
- ARAY $465,251,000.00
- CATX $1,471,000.00
- Revenue This Year
- ARAY $3.87
- CATX N/A
- Revenue Next Year
- ARAY $0.09
- CATX N/A
- P/E Ratio
- ARAY $206.48
- CATX N/A
- Revenue Growth
- ARAY 8.06
- CATX N/A
- 52 Week Low
- ARAY $1.14
- CATX $1.60
- 52 Week High
- ARAY $2.95
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- ARAY 49.83
- CATX 52.04
- Support Level
- ARAY $1.35
- CATX $3.88
- Resistance Level
- ARAY $1.42
- CATX $4.28
- Average True Range (ATR)
- ARAY 0.05
- CATX 0.29
- MACD
- ARAY 0.00
- CATX -0.04
- Stochastic Oscillator
- ARAY 46.67
- CATX 20.56
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.